Please find below the details of upcoming IPO Laxmi Organic Industries Limited.
Laxmi Organic Industries Limited | ||||
Company Details | · Laxmi Organic Industries Limited is a leading manufacturer of Acetyl Intermediates and Specialty Intermediates
with almost three decades of experience in large scale manufacturing of chemicals. Since their inception in 1989, Company has been on a journey of transformation. · Company is currently among the largest manufacturers of ethyl acetate in India with a market share of approximately 30% of the Indian ethyl acetate market (source: Frost & Sullivan Report). Further, post completion of the YCPL Acquisition, their market share in the ethyl acetate market will be further enhanced. · Company is the only manufacturer of diketene derivatives in India with a market share of approximately 55 % of the Indian diketene derivatives market in terms of revenue in Fiscal 2020 and one of the largest portfolios of diketene products (source: Frost & Sullivan Report). · Company’s products are currently divided into two broad categories, namely the Acetyl Intermediates and the Specialty Intermediates. The Acetyl Intermediates include ethyl acetate, acetaldehyde, fuel-grade ethanol and other proprietary solvents, while the Specialty Intermediates comprises of ketene, diketene derivatives namely esters, acetic anhydride, amides, arylides and other chemicals. Company’s products find application in various high-growth industries, including pharmaceuticals, agrochemicals, dyes & pigments, inks & coatings, paints, printing & packaging, flavours & fragrances, adhesives and other industrial applications. · Over the years, they have significantly expanded their scale of operations and global footprint with customers in over 30 countries including China, Netherlands, Russia, Singapore, United Arab Emirates, United Kingdom and United States of America. Company have offices in Leiden (Netherlands), Shanghai (China) and Sharjah (United Arab Emirates) which enables them to assess international demand and increase their customer outreach thereby bolstering their product development initiatives. · Company currently have two manufacturing facilities in Mahad, Maharashtra (the “Manufacturing Facilities”), with one facility dedicated to Acetyl Intermediates (the “AI Manufacturing Facility”) and another dedicated to Specialty Intermediates (the “SI Manufacturing Facility”). They also have two distilleries located in Satara district (the “Jarandeshwar Distillery”) and Kolhapur district in Maharashtra (the “Panchganga Distillery”). Company have two Department of Scientific and Industrial Research, Government of India (“DSIR”) recognized research and development facilities, with state-of-the-art research and development infrastructure to synthesise specialty molecules and advanced intermediates (source: Frost & Sullivan Report). |
|||
Issue Period | Monday, March 15th, 2021 | |||
Wednesday, March 17th, 2021. | ||||
Price Band | Rs.129/- to Rs.130/- per equity shares. | |||
Bid Lot | 115 Equity share and in multiple of 115 equity share thereafter. | |||
Issue Size | Rs. 600.00 Cr. | |||
Issue break-up | QIB – 50 % of the offer – Rs. 300.00 Cr | |||
NIB – 15 % of the offer – Rs. 90.00 Cr | ||||
RET – 35 % of the offer – Rs. 210.00 Cr | ||||
Listing | BSE & NSE | |||
Registrar | Link Intime India Private Limited | |||
UPI | All Retail Applications through brokers are compulsorily in UPI Mode |
Company Financials:
Particulars | For the year/period ended (₹ in millions) | ||||
---|---|---|---|---|---|
30-Sep-20 | 31-Mar-20 | 31-Mar-19 | 31-Mar-18 | ||
Total Assets | 10,371.32 | 10,706.33 | 10,144.88 | 8,947.34 | |
Total Revenue | 8,143.55 | 15,386.21 | 15,743.23 | 13,960.75 | |
Profit After Tax | 454.84 | 702.12 | 723.91 | 756.95 |
Objects of the Issue:
- Investment in subsidiary firm, Yellowstone Fine Chemicals Private Limited (YFCPL) to partly finance the capex to establish a new manufacturing facility.
- To invest in YFCPL for financing working capital requirements.
- To finance the capex for expansion of SI manufacturing facility.
- To finance business working capital requirements.
- To purchase plant and machinery for infrastructure development at SI facility.
- To make prepayment or repayment of borrowings availed by the company and subsidiary, Viva Lifesciences Pvt Ltd (VLPL).
- To meet general corporate purposes.
Laxmi Organic IPO Date & Price Band:
IPO Open: | 15 March 2021 |
IPO Close: | 17 March 2021 |
IPO Size: | Approx ₹600 Crore |
Face Value: | ₹2 Per Equity Share |
Price Band: | ₹129 to ₹130 Per Share |
Listing on: | BSE & NSE |
Retail Portion: | 35% |
Equity: | 55,43,052 Shares |
Laxmi Organic IPO Market Lot:
Minimum Lot Size: | Minimum 115 Shares |
Minimum Amount: | ₹14950 |
Maximum Lot Size: | Maximum 1495 Shares |
Maximum Amount: | ₹194350 |
Laxmi Organic IPO Allotment & Listing:
Basis of Allotment: | 22 March 2021 |
Refunds: | 23 March 2021 |
Credit to Demat Account: | 24 March 2021 |
Listing Date: | 25 March 2021 |
Laxmi Organic IPO Review:
- Apply for Listing Gain and Long Term Gain